News

Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...
Moderna said on Monday its experimental influenza vaccine was found to be 26.6% more effective than a currently approved ...
The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.
In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...
Moderna on Monday said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot in a late-stage trial, clearing a path forward for the product and ...
Moderna’s latest flu vaccine, based on similar mRNA technology integrated in its COVID-19 shot, displayed optimistic outcomes ...
Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...
Moderna had been awarded over $750 million to develop a vaccine against bird flu, which has been circulating in farm animals and sickening people.
The flu vaccine is recommended annually for all Americans 6 months and older, per the Centers for Disease Control and Prevention — but a new study from Cleveland Clinic suggests that it might ...
Who should get a flu vaccine? Nearly everyone aged six months or older should get a flu vaccine, according to the CDC.. The CDC offers rare exceptions for who shouldn't get one, including people ...